The Healthcare Businesswomen’s Association (HBA) announced that 12 healthcare and life science companies have started a partnership to advance gender parity progress in the industry. The founding member companies serve as role models with all 12 organizations supporting internal women’s leadership networks and more than half recognized by national business media outlets for progressive diversity and inclusion programs, along with representing a work force of more than 750,000 employees collectively globally.
While similar corporate partnerships exist, the HBA’s Collaborative is different in that all member companies are in the healthcare and life science business. The twelve founding member companies are Advanced Clinical, Bristol-Myers Squibb, Celgene, Eli Lilly and Company, GlaxoSmithKline, Medidata Solutions, Novartis, Pfizer, Quest Diagnostics, Genentech, a member of the Roche group, and Sanofi.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.